Helius Medical Technologies, Inc. Reports Third Quarter 2022 Financial Results
Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended September 30, 2022
By Helius Medical Technologies, Inc.
Published - Nov 14, 2022, 06:34 AM ET
Last Updated - Mar 28, 2024, 10:42 AM EDT
-- Total Q3 revenue up 80% over prior year --
-- Cash on hand expected to fund operations through 2023 --
-- Company to host call at 8:30am today --
NEWTOWN, Pa., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the quarter ended September 30, 2022.
Third Quarter and Recent Business Updates
